my private podcast channel
Dr. Marty Makary has criticized the Food and Drug Administration for being "captured" by Big Food and Big Pharma. Now, the surgeon and former professor is in charge. In an interview with host Jessica Mendoza, the new FDA head talks about food dyes, AI, vaccines and the big changes he has in store for an agency that regulates one-fifth of consumer spending.
Further Listening:
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Plus: Linda Yaccarino, former CEO of X, lands at eMed Population Health. And NASA’s acting administrator Sean Duffy directs the agency to support more private space stations. Julie Chang hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
A Palestinian activist who helped make the Oscar-winning documentary "No Other Land" was shot dead in a suspected Israeli settler attack in the occupied West Bank. We go to his community to hear about the man and the incident that lead to his death.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
From overvalued stocks to outsized returns, some capital compounders keep breaking the mold.
Today on Motley Fool Money, Emily Flippen, with analysts Sanmeet Deo and Jason Hall, dig into four market beaters and ask: can the flywheels keep spinning? They unpack:
- Earnings from old-school winners Axon and MercadoLibre, including how they turned skeptics into believers with consistent execution
- Results from new-school contenders Hims & Hers and Palantir, both of which face high levels of scrutiny despite strong performance
- Tariff math that matters and where pricing power may blunt cost headwinds
Companies discussed: MELI, AXON, HIMS, PLTR, ZBRA
Host: Emily Flippen, Sanmeet Deo, Jason Hall
Producer: Anand Chokkavelu
Engineer: Dan Boyd, Natasha Hall
Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Insights into the latest Litecoin treasury move with creator Charlie Lee and GSR Chief Strategy Officer Joshua Riezman.
Litecoin is entering the corporate treasury world as Nasdaq-listed biotech firm MEI Pharma raised $100M to fund a Litecoin treasury strategy. Charlie Lee, creator of the altcoin, joins GSR Chief Strategy Officer Joshua Riezman to discuss the recent move and what's next on Litecoin's roadmap.
-
Midnight is introducing a novel approach to token distribution. The Midnight Glacier Drop is a multi-phase distribution of the NIGHT token, aimed at empowering a broad, diverse community to build the future of the Midnight network. Holders of ADA, BTC, ETH, SOL, XRP, BNB, AVAX and BAT are eligible to participate in the first phase.
Help usher in the next generation of blockchain with rational privacy and cooperative tokenomics on the Midnight network. To learn more, visit midnight.gd and prepare for the Midnight Glacier Drop.
-
This episode was hosted by Jennifer Sanasie.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By George Szirtes
Plus: The U.S. trade gap shrank to its lowest level in June since 2023. And India defends its ability to buy Russian oil, despite President Trump’s threats of higher tariffs. Alex Ossola hosts.
Sign up for the WSJ's free What's News newsletter.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Bonus Episode for Aug. 5. Six of the so-called Magnificent Seven companies have reported quarterly earnings, with only Nvidia, the most-valuable of them all, yet to release its results. Heard on the Street’s Asa Fitch talks about how much better it can get for the stocks harnessing AI-mania to propel the stock market. Asa, who also writes the Journal’s new AI newsletter, says that the hyperscalers show no sign of slowing their furious pace of capital investment in infrastructure, but he cautions that continuing to top investors’ lofty expectations is becoming more of a challenge.
Markets AM writer Spencer Jakab hosts this special bonus episode of What's News in Earnings, where we dig into companies’ earnings reports and analyst calls to find out what’s going on under the hood of the American economy.
Sign up for the WSJ's free Markets A.M. newsletter.
Sign up for the WSJ's free WSJ AI & Business.
Learn more about your ad choices. Visit megaphone.fm/adchoices